Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PANCRELIPASE vs PANITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PANCRELIPASE vs PANITUMUMAB: Safety Overview

Metric PANCRELIPASE PANITUMUMAB
Total FAERS Reports 724 10,876
Deaths Reported 66 1,666
Death Rate 9.1% 15.3%
Hospitalizations 281 3,121
Average Patient Age 52.0 yrs 63.0 yrs
% Female Patients 50.4% 36.9%
Manufacturer N/A Amgen Inc
Route N/A INTRAVENOUS
Marketing Status Discontinued Prescription